Improving Overactive Bladder Treatment Access and Adherence Through Personalized Behavioral Modifications and Mobile Technology-Based Interventions

通过个性化行为改变和基于移动技术的干预措施改善膀胱过度活动症治疗的可及性和依从性

• 批准号: 10525607
• 负责人: Ekene Enemchukwu
• 金额: $ 19.53万
• 依托单位: STANFORD UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-08-15 至 2027-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10525607
• 关键词: Adherence; Affect; American; Award; Behavior Therapy; Caring; Chronic; Clinical; Cultural Diversity; Data; Development; Diagnosis; Disease; Evidence based intervention; Evidence based treatment; Female; Funding; Goals; Health; Health Personnel; Health Services Accessibility; Improve Access; Increased frequency of micturition; International; Intervention; Interview; Knowledge; Lead; Low income; Methods; Minority Groups; Outcome; Overactive Bladder; Patient Education; Patient-Focused Outcomes; Patients; Perception; Pharmacotherapy; Pilot Projects; Population; Positioning Attribute; Procedures; Process; Provider; Publishing; Quality of life; Randomized; Research; Research Personnel; Risk; Role; Stigmatization; Structure; Symptoms; Syndrome; Testing; Treatment Efficacy; Underserved Population; Urinary Incontinence; Veterans; Vulnerable Populations; Woman; Women' s Group; barrier to care; base; care seeking; cost; cost effective; design; efficacy trial; ethnic diversity; evidence base; expectation; future implementation; health care delivery; improved; improved outcome; innovation; mHealth; micturition urgency; minimally invasive; mobile application; mobile computing; multidisciplinary; patient expectation; patient oriented; pilot test; pilot trial; provider-level barriers; racial and ethnic; satisfaction; side effect; social health determinants; therapy adherence; therapy duration; therapy outcome; tool; treatment adherence; treatment as usual; treatment planning; urinary; usability

PROJECT SUMMARY/ABSTRACT Poor access and insufficient patient education regarding OAB chronicity, expected outcomes, costs, and potential side effects lead to unrealistic patient perceptions about therapy and suboptimal therapy duration, particularly in vulnerable populations. This thus leads to poor treatment access, adherence, and undertreatment. My long-term goal is to develop as an independently funded investigator and international leader who will pioneer interventions that improve OAB therapy access, adherence and outcomes, thereby reducing the burden of this chronic condition. The overall objective for this K23 proposal is to design an innovative, stakeholder-informed strategy that incorporates barriers to treatment (such as social determinants of health) and improves patient access to therapy options and therapy adherence. The central hypothesis is that unmet patient expectations and knowledge due to lack of access and suboptimal provider-to-patient OAB healthcare delivery are a barrier to treatment adherence. This central hypothesis will be tested pursuing two specific aims: 1. Evaluate an adapted UI mobile health tool for use in a diverse, multicultural population of women with OAB and identify barriers and facilitators to access, treatment adherence and engagement from multiple key stakeholders. 2. Conduct a pilot study to evaluate the usability and feasibility of using a mobile health tool to improve OAB knowledge, engagement and treatment plan adherence in a diverse group of women with OAB. The rationale for the proposed research is that its completion is expected to provide a strong evidence-based framework for the continued development and future implementation of cost-effective, evidence-based interventions to improve OAB therapy access and adherence. Combined these results are expected to have an important positive impact by positioning me to submit a competitive R01 application proposing a randomized controlled efficacy trial for improving therapy access, adherence, and OAB outcomes during the fourth year of this award.

项目摘要/摘要 关于OAB慢性，预期结果，成本和患者教育不足和患者教育不足 潜在的副作用导致患者对治疗和次优疗法持续时间的看法不切实际， 特别是在弱势群体中。因此，这导致治疗障碍，依从性和 不足。我的长期目标是发展为独立资助的调查员和国际 领导者将开拓改善OAB疗法访问，依从性和结果的干预措施，从而 减轻这种慢性病的负担。该K23提案的总体目标是设计 创新的，利益相关者的策略融合了治疗障碍（例如社会决定因素 健康）并改善患者获得治疗选择和治疗依从性。中心假设是 由于缺乏访问权限和次优的提供商对OAB而导致的未满足的患者期望和知识 医疗保健提供是治疗依从性的障碍。该中心假设将进行检验，以追求两个 具体目的：1。评估适用的UI移动健康工具，用于在多种多样的多元文化中使用 具有OAB的妇女，并确定障碍和促进者，以获取，治疗依从性和参与 多个主要利益相关者。 2。进行试点研究以评估使用移动的可用性和可行性 改善OAB知识，参与和治疗计划的健康工具 OAB的妇女。拟议研究的理由是，预计其完成将提供强大的 基于循证的框架，用于持续发展和未来实施具有成本效益的框架， 基于循证的干预措施，以改善OAB治疗的获取和依从性。这些结果结合在一起 预计我将我提交有竞争力的R01申请会产生重要的积极影响 提出一项随机对照疗效试验，以改善治疗访问，依从性和OAB结果 在该奖项的第四年。